Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-21-000504
Filing Date
2021-01-25
Accepted
2021-01-25 16:06:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 CALITHERA BIOSCIENCES, INC. p21-0160sc13g.htm SC 13G 105603
  Complete submission text file 0000902664-21-000504.txt   107215
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

EIN.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Subject) CIK: 0001496671 (see all company filings)

EIN.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88349 | Film No.: 21549713
SIC: 2834 Pharmaceutical Preparations